Cite
HARVARD Citation
Boch, T. et al. (n.d.). Safety and Efficacy of the Cd95-Ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS. Leukemia research. pp. S53-S54. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boch, T. et al. (n.d.). Safety and Efficacy of the Cd95-Ligand Inhibitor Asunercept in Transfusion-Dependent Patients with Low and Intermediate Risk MDS. Leukemia research. pp. S53-S54. [Online].